Works matching IS 11707690 AND DT 2018 AND VI 36 AND IP 5
Results: 10
Cost-Effectiveness Analysis of Lesinurad/Allopurinol Versus Febuxostat for the Management of Gout/Hyperuricemia in Italy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Australian Managed Entry Scheme: Are We Getting it Right?
- Published in:
- 2018
- By:
- Publication type:
- journal article
New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: A Systematic Literature Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reslizumab for Treating Asthma with Elevated Blood Eosinophils Inadequately Controlled by Inhaled Corticosteroids: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cost-Effectiveness Thresholds: the Past, the Present and the Future.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway.
- Published in:
- 2018
- By:
- Publication type:
- journal article